U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07486583) titled 'Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.' on Dec. 07, 2025.
Brief Summary: To evaluate the efficacy of Autologous Whole Blood Therapy versus conventional treatment using fourfold dose of antihistamines in Autologus serum skin test (ASST) positive and negative Chronic Idiopathic Urticaria (CIU) patients and suggest its possible mechanism of action.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Chronic Idiopathic Urticaria
Intervention:
BIOLOGICAL: Autologous whole blood therapy
The AWBT test group patients will receive 8 doses of autologous whole blood therapy (AWBT) once wee...